Tolerion
South San Francisco
About Tolerion
Tolerion is a biotechnology company addressing the cause of autoimmune diseases through bio-therapeutic. They use our novel antigen-specific immune tolerance induction platform to engineer product candidates that restore balance in autoimmune conditions in which self-antigens (or “autoantigens”) incite a destructive immune response. Tolerion was founded in 2001 and is headquartered in South San Francisco, California, USA.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $43.0M
- Last round: Series Unknown (Jan 2020)
- Website: tolerion.bio
- Phone: +415-795-5800
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/tolerion-109208 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.